Clinical significance of trisomy 8 that emerges during therapy in chronic myeloid leukemia.

about

Clinical and prognostic significance of e1a2 BCR-ABL1 transcript subtype in chronic myeloid leukemia.Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm.

P2860

Q41316578-CE8C2453-49C5-4EEF-BA5B-2925BFC5CC7E Q48171349-C7F15507-92D2-40B3-8A6C-7AA99BE78019

P2860

Clinical significance of trisomy 8 that emerges during therapy in chronic myeloid leukemia.

Item

http://www.wikidata.org/entity/Q37490012

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Clinical significance of triso ...... y in chronic myeloid leukemia.

@en

Clinical significance of triso ...... y in chronic myeloid leukemia.

@nl

type

Item

label

Clinical significance of triso ...... y in chronic myeloid leukemia.

@en

Clinical significance of triso ...... y in chronic myeloid leukemia.

@nl

prefLabel

Clinical significance of triso ...... y in chronic myeloid leukemia.

@en

Clinical significance of triso ...... y in chronic myeloid leukemia.

@nl

P1476

Clinical significance of triso ...... py in chronic myeloid leukemia

@en

P2093

C C Yin

http://www.w3.org/2001/XMLSchema#string

C E Bueso-Ramos

http://www.w3.org/2001/XMLSchema#string

L J Medeiros

http://www.w3.org/2001/XMLSchema#string

S Bai

http://www.w3.org/2001/XMLSchema#string

S Li

http://www.w3.org/2001/XMLSchema#string

W Wang

http://www.w3.org/2001/XMLSchema#string

Z Chen

http://www.w3.org/2001/XMLSchema#string

Z Hu

http://www.w3.org/2001/XMLSchema#string

P2860

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.

Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors.

Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.

Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.

Survival outcomes for clonal evolution in chronic myeloid leukemia patients on second generation tyrosine kinase inhibitor therapy.

Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV.

Cytogenetic profile of 1,863 Ph/BCR-ABL-positive chronic myelogenous leukemia patients from the Chinese population.

Impact of trisomy 8 on treatment response and survival of patients with chronic myelogenous leukemia in the era of tyrosine kinase inhibitors.

P2888

bcj.2016.96

P304

e490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BCJ.2016.96

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shimin Hu

P577

2016-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27813536

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia

P932

5148060

http://www.w3.org/2001/XMLSchema#string

Clinical significance of trisomy 8 that emerges during therapy in chronic myeloid leukemia.

about

P2860

P2860

Clinical significance of trisomy 8 that emerges during therapy in chronic myeloid leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932